Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Ming Hu

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Scientific Reports|November 23, 2016
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor RegressionGuangjie Yu, Yuhuan Li, Zhihua Cui, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptideSybren L Meijer, Annemieke Dols, Shawn M Jensen, et al.
Oncoimmunology|September 14, 2016
Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathwayMeng Zhou, Zhifa Wen, Feng Cheng, et al.
Cellular Immunology|January 9, 2007
Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccinationHideyuki Kuriyama, Satoshi Watanabe, Jorgen Kjaergaard, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Oncoimmunology|November 20, 2012
Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPsYongxiang Yi, Zhenxian Zhou, Su Shu, et al.
Journal of Translational Medicine|April 17, 2014
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsWei Ye, Yun Xing, Christopher Paustian, et al.
Oncoimmunology|June 7, 2018
Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophilsRong Gao, Jie Ma, Zhifa Wen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in miceMichael J Gough, Marka R Crittenden, MaryClare Sarff, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Scientific Reports|November 23, 2016
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor RegressionGuangjie Yu, Yuhuan Li, Zhihua Cui, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2007
Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptideSybren L Meijer, Annemieke Dols, Shawn M Jensen, et al.
Oncoimmunology|September 14, 2016
Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathwayMeng Zhou, Zhifa Wen, Feng Cheng, et al.
Cellular Immunology|January 9, 2007
Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccinationHideyuki Kuriyama, Satoshi Watanabe, Jorgen Kjaergaard, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Oncoimmunology|November 20, 2012
Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPsYongxiang Yi, Zhenxian Zhou, Su Shu, et al.
Journal of Translational Medicine|April 17, 2014
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsWei Ye, Yun Xing, Christopher Paustian, et al.
Oncoimmunology|June 7, 2018
Tumor cell-released autophagosomes (TRAP) enhance apoptosis and immunosuppressive functions of neutrophilsRong Gao, Jie Ma, Zhifa Wen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in miceMichael J Gough, Marka R Crittenden, MaryClare Sarff, et al.
Pageof 8